Yield10 Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2003
Revenue	0.06	0.45	0.61	0.8	0.81	0.56	0.94	1.16	1.35	2.8	Upgrade
Revenue Growth (YoY)	-86.67%	-26.71%	-23.15%	-0.87%	44.96%	-41.10%	-18.55%	-14.15%	-51.79%	-25.89%	Upgrade
Cost of Revenue	0	0	0	0	0	0	0	0	0	1.48	Upgrade
Gross Profit	0.06	0.45	0.61	0.8	0.81	0.56	0.94	1.16	1.35	1.32	Upgrade
Selling, General & Admin	6.15	6.15	6.11	5.05	4.55	5.09	5.63	5.74	7.22	10.81	Upgrade
Research & Development	8.32	7.75	6.2	5.36	4.85	4.78	4.6	5.67	6.6	17.34	Upgrade
Operating Expenses	14.48	13.9	12.31	10.41	9.4	9.88	10.23	11.41	13.82	28.15	Upgrade
Operating Income	-14.42	-13.45	-11.69	-9.61	-8.6	-9.32	-9.28	-10.25	-12.47	-26.83	Upgrade
Other Expense / Income	0.04	-0.04	-0.7	0.54	4.61	-0.13	0.11	-1.55	11.21	2.71	Upgrade
Pretax Income	-14.46	-13.41	-11	-10.15	-13.21	-9.19	-9.4	-8.7	-23.68	-29.53	Upgrade
Income Tax	0	0.16	0.04	0.06	-0.25	0	0	-1.1	0	0	Upgrade
Net Income	-14.46	-13.57	-11.03	-10.21	-12.96	-9.19	-9.4	-7.6	-23.68	-29.53	Upgrade
Preferred Dividends	0	0	0	0	0	0	1.43	0	0	0	Upgrade
Net Income Common	-14.46	-13.57	-11.03	-10.21	-12.96	-9.19	-10.82	-7.6	-23.68	-29.53	Upgrade
Shares Outstanding (Basic)	8	5	5	2	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	8	5	5	2	0	0	0	0	0	0	Upgrade
Shares Change	61.69%	3.86%	99.38%	550.27%	46.98%	202.03%	18.24%	11.22%	144.15%	78.28%	Upgrade
EPS (Basic)	-1.82	-2.76	-2.33	-4.30	-35.50	-36.99	-131.60	-109.20	-380.00	-1152.00	Upgrade
EPS (Diluted)	-1.82	-2.76	-2.33	-4.30	-35.50	-36.99	-131.60	-109.20	-380.00	-1152.00	Upgrade
Free Cash Flow	-10.11	-11.56	-9.44	-8.73	-8.72	-8.8	-8.21	-15.16	-22.52	-24.67	Upgrade
Free Cash Flow Per Share	-1.27	-2.35	-2.00	-3.68	-23.88	-35.42	-99.83	-217.98	-360.17	-963.24	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	47.07%	Upgrade
Operating Margin	-24028.33%	-2989.11%	-1904.23%	-1202.63%	-1066.50%	-1676.08%	-983.37%	-884.21%	-923.63%	-958.18%	Upgrade
Profit Margin	-24091.67%	-3014.67%	-1796.58%	-1277.35%	-1607.44%	-1651.98%	-1146.50%	-656.08%	-1754.15%	-1054.79%	Upgrade
Free Cash Flow Margin	-16856.67%	-2568.44%	-1537.79%	-1091.99%	-1081.27%	-1582.01%	-869.49%	-1307.68%	-1667.93%	-880.89%	Upgrade
EBITDA	-13.86	-12.75	-10.42	-9.54	-11.38	-8.4	-9.19	-8.19	-23.42	-29.03	Upgrade
EBITDA Margin	-23095.00%	-2834.22%	-1696.58%	-1193.87%	-1412.16%	-1510.97%	-973.52%	-706.30%	-1734.52%	-1036.68%	Upgrade
Depreciation & Amortization	0.6	0.66	0.58	0.61	1.83	0.78	0.21	0.52	0.27	0.51	Upgrade
EBIT	-14.46	-13.41	-11	-10.15	-13.21	-9.19	-9.4	-8.7	-23.68	-29.53	Upgrade
EBIT Margin	-24091.67%	-2980.00%	-1790.72%	-1270.34%	-1638.96%	-1651.98%	-995.34%	-750.73%	-1754.15%	-1054.79%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).